1. Home
  2. ACAD
  3. ACAD News

Latest ACADIA Pharmaceuticals Inc. (ACAD) News on July 27, 2024

Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
ACAD

Business Wire

2 days ago

Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024

Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
ACAD

Business Wire

8 days ago

Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med

ACAD

MT Newswires

a month ago

BMO Initiates ACADIA Pharmaceuticals at Outperform With $31 Price Target

Why Is ACADIA Pharmaceuticals Inc (ACAD) One of the Best Debt Free Halal Stocks According to Hedge Funds?
ACAD

Insider Monkey

a month ago

Why Is ACADIA Pharmaceuticals Inc (ACAD) One of the Best Debt Free Halal Stocks According to Hedge Funds?

Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
ACAD

Business Wire

a month ago

Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
ACAD

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
ACAD

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
ACAD

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
ACAD

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

ACAD

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
ACAD

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
ACAD

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
ACAD

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

It's Probably Less Likely That ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Will See A Huge Pay Rise This Year
ACAD

Simply Wall St.

2 months ago

It's Probably Less Likely That ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Will See A Huge Pay Rise This Year

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ACAD

Business Wire

2 months ago

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
ACAD

Business Wire

2 months ago

Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
ACAD

Simply Wall St.

3 months ago

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

ACAD

GuruFocus.com

3 months ago

ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches

ACAD

MT Newswires

3 months ago

UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating

ACAD

MT Newswires

3 months ago

Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating

ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ACAD

Simply Wall St.

3 months ago

ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
ACAD

Insider Monkey

3 months ago

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript

ACAD

MT Newswires

3 months ago

Stifel Adjusts Price Target on ACADIA Pharmaceuticals to $21 From $26, Keeps Hold Rating

ACAD

GuruFocus.com

3 months ago

ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
ACAD

Zacks

3 months ago

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates

ACAD

Associated Press Finance

3 months ago

Acadia: Q1 Earnings Snapshot

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
ACAD

Zacks

3 months ago

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD)
ACAD

GuruFocus.com

3 months ago

Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD)

ACAD

MT Newswires

3 months ago

UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating

Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship

ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago
ACAD

Simply Wall St.

3 months ago

ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024

Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
ACAD

Business Wire

3 months ago

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares
ACAD

GuruFocus.com

4 months ago

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development
ACAD

Business Wire

4 months ago

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development

Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
ACAD

Business Wire

4 months ago

Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares
ACAD

GuruFocus.com

4 months ago

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ACAD

Business Wire

4 months ago

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day
ACAD

Business Wire

4 months ago

Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day

Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study
ACAD

Investor's Business Daily

4 months ago

Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study

ACAD

Reuters

5 months ago

UPDATE 2-Acadia to stop trials of antipsychotic drug after it fails schizophrenia study

ACAD

Reuters

5 months ago

Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study

Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia
ACAD

Business Wire

5 months ago

Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia

Analysts Have Made A Financial Statement On ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Yearly Report
ACAD

Simply Wall St.

5 months ago

Analysts Have Made A Financial Statement On ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Yearly Report

Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024
ACAD

Business Wire

5 months ago

Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript
ACAD

Insider Monkey

5 months ago

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
ACAD

Simply Wall St.

5 months ago

ACADIA Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Acadia Stock Dives As Unexpected Seasonality Rocks Its Most High-Profile Launch
ACAD

Investor's Business Daily

5 months ago

Acadia Stock Dives As Unexpected Seasonality Rocks Its Most High-Profile Launch

Acadia (ACAD) Q4 Earnings Lag, Sales Beat Estimates, Stock Down
ACAD

Zacks

5 months ago

Acadia (ACAD) Q4 Earnings Lag, Sales Beat Estimates, Stock Down

Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
ACAD

Zacks

5 months ago

Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates

ACAD

GuruFocus.com

5 months ago

ACADIA Pharmaceuticals Inc. Reports Strong Revenue Growth in Q4 and Full Year 2023

ACAD

Associated Press Finance

5 months ago

Acadia: Q4 Earnings Snapshot

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
ACAD

Business Wire

5 months ago

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) On The Verge Of Breaking Even
ACAD

Simply Wall St.

5 months ago

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) On The Verge Of Breaking Even

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ACAD

Business Wire

5 months ago

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
ACAD

Zacks

5 months ago

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
ACAD

Business Wire

5 months ago

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

The 3 Most Undervalued Biotech Stocks to Buy in February 2024
ACAD

InvestorPlace

6 months ago

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

Acadia Announces Additions to Executive Team
ACAD

Business Wire

6 months ago

Acadia Announces Additions to Executive Team

20 Countries With The Highest Number of Drug Trafficking in the World
ACAD

Insider Monkey

6 months ago

20 Countries With The Highest Number of Drug Trafficking in the World

ACAD

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Western Alliance Bancorp Earnings Call

Alkermes (ALKS) Registers a Bigger Fall Than the Market: Important Facts to Note
ACAD

Zacks

6 months ago

Alkermes (ALKS) Registers a Bigger Fall Than the Market: Important Facts to Note

Carvana (CVNA) Advances While Market Declines: Some Information for Investors
ACAD

Zacks

6 months ago

Carvana (CVNA) Advances While Market Declines: Some Information for Investors

Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US
ACAD

Insider Monkey

6 months ago

Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
ACAD

Investor's Business Daily

6 months ago

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

Will Qualys (QLYS) Beat Estimates Again in Its Next Earnings Report?
ACAD

Zacks

6 months ago

Will Qualys (QLYS) Beat Estimates Again in Its Next Earnings Report?

Virtus Investment Partners (VRTS) Earnings Expected to Grow: Should You Buy?
ACAD

Zacks

6 months ago

Virtus Investment Partners (VRTS) Earnings Expected to Grow: Should You Buy?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
ACAD

Zacks

6 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day
ACAD

Zacks

6 months ago

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
ACAD

GlobeNewswire

6 months ago

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application

ACAD

Morningstar Research

6 months ago

Analyst Report: The Descartes Systems Group Inc.

Vince McMahon Accused of Sex Trafficking by WWE Staffer He Paid to Keep Quiet
ACAD

The Wall Street Journal

6 months ago

Vince McMahon Accused of Sex Trafficking by WWE Staffer He Paid to Keep Quiet

ACAD

Associated Press Finance

6 months ago

Western Alliance: Q4 Earnings Snapshot

Western Alliance Bancorp (WAL) Reports Mixed Financial Results for Q4 and Full Year 2023
ACAD

GuruFocus.com

6 months ago

Western Alliance Bancorp (WAL) Reports Mixed Financial Results for Q4 and Full Year 2023

Western Alliance Bancorporation Reports Fourth Quarter and Full Year 2023 Financial Results
ACAD

Business Wire

6 months ago

Western Alliance Bancorporation Reports Fourth Quarter and Full Year 2023 Financial Results

Carvana to Report Fourth Quarter and Fiscal Year 2023 and Host Quarterly Conference Call on February 22
ACAD

Business Wire

6 months ago

Carvana to Report Fourth Quarter and Fiscal Year 2023 and Host Quarterly Conference Call on February 22

Procore Announces Timing of Fourth Quarter and Full Fiscal Year 2023 Earnings Call
ACAD

Business Wire

6 months ago

Procore Announces Timing of Fourth Quarter and Full Fiscal Year 2023 Earnings Call

ACAD

Business Wire

6 months ago

Donaldson Company Declares Quarterly Cash Dividend

Prosperity Bancshares, Inc. (NYSE:PB) Q4 2024 Earnings Call Transcript
ACAD

Insider Monkey

6 months ago

Prosperity Bancshares, Inc. (NYSE:PB) Q4 2024 Earnings Call Transcript

Janus Henderson Group plc (JHG) Expected to Beat Earnings Estimates: Should You Buy?
ACAD

Zacks

6 months ago

Janus Henderson Group plc (JHG) Expected to Beat Earnings Estimates: Should You Buy?

MKS Instruments Selected as a 2024 Campus Forward Award Winner by RippleMatch
ACAD

GlobeNewswire

6 months ago

MKS Instruments Selected as a 2024 Campus Forward Award Winner by RippleMatch

10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
ACAD

Insider Monkey

6 months ago

10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts

MKS Instruments Showcases Customer-Focused Photonics Innovations at SPIE’s Photonics West 2024
ACAD

GlobeNewswire

6 months ago

MKS Instruments Showcases Customer-Focused Photonics Innovations at SPIE’s Photonics West 2024

Invesco Ltd (IVZ) Reports Mixed Fourth Quarter Amidst Market Challenges
ACAD

GuruFocus.com

6 months ago

Invesco Ltd (IVZ) Reports Mixed Fourth Quarter Amidst Market Challenges

Will Janus Henderson Group plc (JHG) Beat Estimates Again in Its Next Earnings Report?
ACAD

Zacks

6 months ago

Will Janus Henderson Group plc (JHG) Beat Estimates Again in Its Next Earnings Report?

Where Will CRISPR Therapeutics Be in 5 Years?
ACAD

Motley Fool

6 months ago

Where Will CRISPR Therapeutics Be in 5 Years?

ESAB Corporation (ESAB) Soars to 52-Week High, Time to Cash Out?
ACAD

Zacks

6 months ago

ESAB Corporation (ESAB) Soars to 52-Week High, Time to Cash Out?

Aurora to Host Fourth Quarter 2023 Business Review Conference Call on February 14, 2024
ACAD

Business Wire

6 months ago

Aurora to Host Fourth Quarter 2023 Business Review Conference Call on February 14, 2024

Carvana Raises the Bar in Online Auto Retail with Same Day Delivery Expansion to Birmingham
ACAD

Business Wire

6 months ago

Carvana Raises the Bar in Online Auto Retail with Same Day Delivery Expansion to Birmingham

Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?
ACAD

Zacks

6 months ago

Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?

ACAD

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Invesco Ltd Earnings Call

Invesco Canada announces cash distributions for its ETFs
ACAD

CNW Group

6 months ago

Invesco Canada announces cash distributions for its ETFs

1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
ACAD

Motley Fool

6 months ago

1 Setback and 1 Opportunity for CRISPR Therapeutics Stock

Fuel to the Fire: 3 Short-Squeeze Candidates
ACAD

Zacks

6 months ago

Fuel to the Fire: 3 Short-Squeeze Candidates

Here’s Why Western Alliance Bancorp (WAL) Share was Up 40%
ACAD

Insider Monkey

6 months ago

Here’s Why Western Alliance Bancorp (WAL) Share was Up 40%

MKS Instruments Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
ACAD

GlobeNewswire

6 months ago

MKS Instruments Announces Fourth Quarter and Full Year 2023 Earnings Conference Call

Share on Social Networks: